Trinity Biotech PLC (TRIB)
1.30
0.00 (0.00%)
USD |
NASDAQ |
Nov 21, 16:00
1.30
0.00 (0.00%)
After-Hours: 07:36
Trinity Biotech Max Drawdown (5Y): 96.74% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 96.74% |
| September 30, 2024 | 96.74% |
| August 31, 2024 | 96.74% |
| July 31, 2024 | 96.74% |
| June 30, 2024 | 96.74% |
| May 31, 2024 | 96.74% |
| April 30, 2024 | 96.74% |
| March 31, 2024 | 96.74% |
| February 29, 2024 | 96.74% |
| January 31, 2024 | 96.74% |
| December 31, 2023 | 96.74% |
| November 30, 2023 | 96.74% |
| October 31, 2023 | 96.74% |
| September 30, 2023 | 96.74% |
| August 31, 2023 | 96.74% |
| July 31, 2023 | 96.74% |
| June 30, 2023 | 96.74% |
| May 31, 2023 | 96.74% |
| April 30, 2023 | 96.74% |
| March 31, 2023 | 96.74% |
| February 28, 2023 | 96.74% |
| January 31, 2023 | 96.74% |
| December 31, 2022 | 96.74% |
| November 30, 2022 | 96.74% |
| October 31, 2022 | 96.74% |
| Date | Value |
|---|---|
| September 30, 2022 | 96.74% |
| August 31, 2022 | 96.74% |
| July 31, 2022 | 96.74% |
| June 30, 2022 | 96.74% |
| May 31, 2022 | 96.74% |
| April 30, 2022 | 96.74% |
| March 31, 2022 | 96.74% |
| February 28, 2022 | 96.74% |
| January 31, 2022 | 96.74% |
| December 31, 2021 | 96.74% |
| November 30, 2021 | 96.74% |
| October 31, 2021 | 96.74% |
| September 30, 2021 | 96.74% |
| August 31, 2021 | 96.74% |
| July 31, 2021 | 96.74% |
| June 30, 2021 | 96.74% |
| May 31, 2021 | 96.74% |
| April 30, 2021 | 96.74% |
| March 31, 2021 | 96.74% |
| February 28, 2021 | 96.74% |
| January 31, 2021 | 96.74% |
| December 31, 2020 | 96.74% |
| November 30, 2020 | 96.74% |
| October 31, 2020 | 96.74% |
| September 30, 2020 | 96.74% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
96.50%
Minimum
Nov 2019
96.74%
Maximum
Mar 2020
96.73%
Average
96.74%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| Amarin Corp PLC | 97.65% |
| DBV Technologies SA | 97.67% |
| Ascendis Pharma AS | 61.72% |
| Cellectis SA | 97.08% |
| Adaptimmune Therapeutics PLC | 96.57% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -31.43 |
| Beta (5Y) | 1.130 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 83.56% |
| Historical Sharpe Ratio (5Y) | -0.2017 |
| Historical Sortino (5Y) | -0.4799 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 30.43% |